Premium
Response to Bevacizumab for the treatment of Rendu‐Osler disease—A note of caution
Author(s) -
DupuisGirod Sophie,
Buscarini Elisabetta
Publication year - 2017
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/liv.13385
Subject(s) - medicine , citation , bevacizumab , humanities , telangiectasia , library science , surgery , art , computer science , chemotherapy